TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Immuron Limited ( (AU:IMC) ) is now available.
Immuron Limited has announced the quotation of 1,133,840 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of October 20, 2025. This move is part of previously announced transactions and could potentially enhance the company’s market presence and liquidity, impacting its operations and positioning within the biotechnology sector.
More about Immuron Limited
Immuron Limited operates in the biotechnology industry, focusing on the development and commercialization of oral immunotherapy products for the treatment of gut-mediated diseases.
YTD Price Performance: 1.27%
Average Trading Volume: 203,461
Technical Sentiment Signal: Hold
Current Market Cap: A$21.46M
For detailed information about IMC stock, go to TipRanks’ Stock Analysis page.